Mutated trimeric RBD vaccines: a platform against variants of concern

Mutated trimeric RBD vaccines: a platform against variants of concern

Bibliographic Details
Main Authors:	Belén Aparicio, Juan J. Lasarte, Pablo Sarobe
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-04-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-023-01426-3

Similar Items

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
by: Belén Aparicio, et al.
Published: (2023-01-01)

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
by: Belén Aparicio, et al.
Published: (2023-03-01)

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma
by: Leyre Silva, et al.
Published: (2020-11-01)

A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
by: Jing Zhang, et al.
Published: (2022-08-01)

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
by: David Repáraz, et al.
Published: (2022-02-01)

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
by: Cai He, et al.
Published: (2022-09-01)

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern
by: Mai Komori, et al.
Published: (2023-05-01)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
by: Jinkai Zang, et al.
Published: (2022-06-01)

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern
by: Erika Rudi, et al.
Published: (2022-09-01)

Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
by: Changcai Teng, et al.
Published: (2022-12-01)

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
by: Belen Aparicio, et al.
Published: (2024-12-01)

Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
by: Cong Liu, et al.
Published: (2022-05-01)

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
by: Lin Yang, et al.
Published: (2021-11-01)

A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants
by: Feixia Gao, et al.
Published: (2023-01-01)

Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants
by: Nidhi Mittal, et al.
Published: (2023-10-01)

Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
by: Cai He, et al.
Published: (2023-03-01)

Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidates
by: Matthew Stuible, et al.
Published: (2023-10-01)

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
by: David Repáraz, et al.
Published: (2022-10-01)

Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
by: Hong Lei, et al.
Published: (2022-05-01)

Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
by: Laura Marcos-Villar, et al.
Published: (2024-03-01)

Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants
by: Tarlan Mamedov, et al.
Published: (2023-08-01)

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells
by: Guillaume Gerez, et al.
Published: (2022-08-01)

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain
by: Jiajing Wu, et al.
Published: (2022-01-01)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz Al-Fattah Yahaya, et al.
Published: (2023-02-01)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
by: Lianlian Bian, et al.
Published: (2022-11-01)

Impact of glycosylation and length of RBD of SARS-CoV-2 S protein on the immunogenicity of RBD protein vaccines
by: ZHANG Ting, WANG Zhi-rong, XU Xue-mei
Published: (2020-12-01)

A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants
by: Yu Liu, et al.
Published: (2022-11-01)

SARS-CoV-2 RBD and Its Variants Can Induce Platelet Activation and Clearance: Implications for Antibody Therapy and Vaccinations against COVID-19
by: Xiaoying Ma, et al.
Published: (2023-01-01)

Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2
by: Zhikai Zhang, et al.
Published: (2022-09-01)

Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.
by: Medina-Ramírez, M, et al.
Published: (2017)

Stabilized diverse HIV-1 envelope trimers for vaccine design
by: Qian Wang, et al.
Published: (2020-01-01)

Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein
by: Julia T. Castro, et al.
Published: (2022-08-01)

A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
by: Ziyan Wang, et al.
Published: (2022-11-01)

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
by: Deyan Luo, et al.
Published: (2022-09-01)

Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults
by: Karina A. Pasquevich, et al.
Published: (2023-07-01)

Real-world effectiveness of the inactivated COVID-19 vaccines against variant of concerns: meta-analysis
by: Muhammad Usman Sarwar, et al.
Published: (2024-02-01)

Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
by: Monika Kumari, et al.
Published: (2023-06-01)

Development of an RBD-Fc fusion vaccine for COVID-19
by: Yisheng Sun, et al.
Published: (2024-01-01)

Improving the Antigenicity of SARS-CoV-2 Vaccine Genes by Merging Mutations from Different Variants of Concern
by: Susanne Herwig, et al.
Published: (2024-02-01)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
by: Wai-Yim Ching, et al.
Published: (2022-09-01)